A novel mixed-ligand antimycobacterial dimeric copper complex of ciprofloxacin and phenanthroline

Bioorg Med Chem Lett. 2004 Jun 21;14(12):3027-32. doi: 10.1016/j.bmcl.2004.04.043.

Abstract

A novel mixed-ligand Cu(II) complex of ciprofloxacin (cfH) and phenanthroline, is found to crystallize as a dimeric moiety containing monocationic and dicationic species. Two such dimeric moieties are found in the same unit cell leading to a dicationic cluster. The higher negative redox potential for this cluster dampens its antimycobacterial activity against M. smegmatis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Ciprofloxacin / chemistry*
  • Ciprofloxacin / pharmacology
  • Copper / chemistry*
  • Copper / pharmacology
  • Ligands
  • Mycobacterium smegmatis / drug effects
  • Mycobacterium smegmatis / growth & development
  • Phenanthrolines / chemistry*
  • Phenanthrolines / pharmacology

Substances

  • Anti-Bacterial Agents
  • Ligands
  • Phenanthrolines
  • Ciprofloxacin
  • Copper